Cite Them Right 11th edition - Harvard

Tempfer, C., Brucker, S., Juhasz-Böss, I., Mallmann, P., Steiner, E., Denschlag, D., Hillemanns, P., Wallwiener, M. und Beckmann, M.W. (2024) Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer [cd]. Freiburg: Universität. doi:10.1055/a-2145-1545.

Chicago Manual of Style 17th edition (full note)

Tempfer, Clemens, Sara Brucker, Ingolf Juhasz-Böss, Peter Mallmann, Eric Steiner, Dominik Denschlag, Peter Hillemanns, Markus Wallwiener, und Matthias Wilhelm Beckmann. Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer. Cd. Freiburg: Universität, [2024?], Freiburg: Universität, [2024?]. https://doi.org/10.1055/a-2145-1545.

American Psychological Association 7th edition

Tempfer, C., Brucker, S., Juhasz-Böss, I., Mallmann, P., Steiner, E., Denschlag, D., Hillemanns, P., Wallwiener, M., & Beckmann, M. W. (ca. 2024). Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer [Cd]. Universität. https://doi.org/10.1055/a-2145-1545

Modern Language Association 9th edition

Tempfer, C., S. Brucker, I. Juhasz-Böss, P. Mallmann, E. Steiner, D. Denschlag, P. Hillemanns, M. Wallwiener, und M. W. Beckmann. Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer. cd, Universität, 2024, https://doi.org/10.1055/a-2145-1545.

ISO-690 (author-date, Deutsch)

TEMPFER, Clemens, Sara BRUCKER, Ingolf JUHASZ-BÖSS, Peter MALLMANN, Eric STEINER, Dominik DENSCHLAG, Peter HILLEMANNS, Markus WALLWIENER und Matthias Wilhelm BECKMANN, 2024. Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer. Freiburg: Universität

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.